Controlling Prescribing through "Preferred Drug" Targets-The Bavarian Experience

The rising costs of drugs are putting health care systems under pressure. We report on the Bavarian Drug Agreement, which employs prescribing targets for preferred and generic drugs in ambulatory care. Under this agreement, providers are regularly profiled with individual feedback but also possible...

Full description

Saved in:
Bibliographic Details
Published in:International journal of environmental research and public health 2024-09, Vol.21 (9), p.1174
Main Authors: Gollnick, Julia, Zeschick, Nikoletta, Muth, Julia, Hörbrand, Franziska, Behnke, Kerstin, Killian, Peter, Sebastiao, Maria, Kühlein, Thomas, Donner-Banzhoff, Norbert
Format: Article
Language:English
Subjects:
Cardiology
Compliance
Costs
Datasets
Drug Prescriptions - statistics & numerical data
Drugs, Generic - therapeutic use
Efficiency
Family physicians
Generic drugs
Germany
Health care policy
Humans
Internal medicine
Pediatrics
Practice Patterns, Physicians' - statistics & numerical data
Prescription drugs
Primary care
Sanctions
Specialization
Surveillance
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The rising costs of drugs are putting health care systems under pressure. We report on the Bavarian Drug Agreement, which employs prescribing targets for preferred and generic drugs in ambulatory care. Under this agreement, providers are regularly profiled with individual feedback but also possible sanctions. We investigated the degree to which targets were being met (or not) and why failure occurred. We analysed prescribing data aggregated by practice for the quarter 1/2018. We chose eight specialisation groups and analysed their drug targets with a high prescribing volume, widely missed drug targets (
ISSN:1660-4601
1661-7827
1660-4601
DOI:10.3390/ijerph21091174